At Qnexa hearing, public commenters are split on the drug's value
| Qnexa, an investigational drug to promote weight loss, has divided public health advocates, based on comments made Wednesday at a Food and Drug Administration advisory committee hearing. The advisory committee will vote later Wednesday in Silver Spring … See all stories on this topic » |
 Los Angeles Times |
